Guam Issues First Cannabis Cultivation Permit Seven Years After Legalization
The territory's Cannabis Control Board approved the island's first commercial grower license on June 23, 2026.

Serene tropical beach with palm trees under a bright blue sky, perfect for relaxation.
First Permit Ends Seven-Year Regulatory Delay
Guam's Cannabis Control Board approved the territory's first commercial cultivation permit on June 23, 2026, marking the first operational license issued under the island's adult-use cannabis program. Voters approved recreational cannabis in the November 2019 general election via Guam Public Law 35-55. But regulatory delays and funding gaps prevented the Cannabis Control Board from finalizing licensing rules until 2025. The board published final cultivation regulations in December 2025. Applications opened in January 2026.
The permit recipient's identity wasn't disclosed in the board's June 23 announcement. Guam law doesn't require public disclosure of applicant names until final license issuance, according to the Cannabis Control Board's administrative rules published in the Guam Administrative Code, Title 10, Chapter 10.
Regulatory Framework Under Public Law 35-55
Guam Public Law 35-55, enacted in April 2019 and approved by voters in November 2019, authorized the Cannabis Control Board to issue five license types: cultivation, manufacturing, testing, retail, and transportation. The law capped cultivation licenses at 10 for the first two years of the program, with no cap on manufacturing, testing, or retail licenses. The board hasn't yet issued licenses in the other four categories.
Cultivation permits allow holders to grow cannabis in secure indoor or outdoor facilities, subject to inspection by the Department of Public Health and Social Services. The law doesn't specify canopy limits, leaving cultivation scale to the board's discretion. The board's December 2025 rules set a 5,000-square-foot canopy cap for initial cultivation permits, expandable to 10,000 square feet after one year of compliant operation.
Why the Seven-Year Gap
The Cannabis Control Board didn't receive dedicated funding until fiscal year 2024, delaying rulemaking and staffing. Public Law 35-55 established the board in 2019, but it operated without a budget or full-time staff until the Guam Legislature appropriated $1.2 million in the FY2024 budget, approved in September 2023. The board hired its first executive director in January 2024. Draft cultivation rules appeared in June 2024.
Public comment periods and revisions extended the rulemaking timeline through November 2025. The board received 47 public comments on the draft cultivation rules, primarily concerning canopy limits, security requirements, and application fees. Final rules, published December 15, 2025, set a $5,000 application fee and a $10,000 annual license fee for cultivation permits.
Next Steps for Guam's Cannabis Market
The Cannabis Control Board expects to issue the remaining nine initial cultivation permits by September 2026, according to the board's June 2026 meeting minutes. Twenty-three cultivation applications submitted between January and May 2026 are under review. Retail and manufacturing license applications are expected to open in the fourth quarter of 2026, pending final rulemaking for those categories.
Guam's cannabis market will compete with illegal imports from the Philippines and unregulated local grows that have operated since the 2019 legalization vote. The board estimates the island's annual cannabis demand at 2,500 pounds, based on a 2025 survey conducted by the University of Guam's Center for Island Sustainability. Licensed cultivation at the 5,000-square-foot canopy cap could produce approximately 1,500 pounds annually per facility, according to the board's economic impact analysis published in March 2026.
Implications for U.S. Territory Cannabis Programs
Guam joins the U.S. Virgin Islands and the Northern Mariana Islands as U.S. territories with legal adult-use cannabis programs, though all three have faced multi-year implementation delays. The U.S. Virgin Islands legalized cannabis in January 2019 but didn't issue its first retail license until March 2025. The Northern Mariana Islands legalized in November 2018 and issued its first cultivation license in July 2023. Puerto Rico and American Samoa haven't legalized adult-use cannabis.
For full background on this story, see the CannIntel topic hub on Guam's cannabis program.
The next signal: whether the board meets its September 2026 target for the remaining nine cultivation permits, and whether retail rulemaking slips past the Q4 2026 timeline. Operators are watching whether Guam's canopy caps and fee structure attract mainland MSOs or remain accessible only to local growers.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Asheville's Realbudz Dispensary Operates in Legal Gray Zone as NC Debate Stalls
The storefront sells cannabis products openly while state lawmakers remain deadlocked on legalization.

Connecticut finalizes tribal cannabis compact to expand market access
The state formalized an agreement allowing tribal nations to enter the cannabis industry, opening new retail and cultivation opportunities.

White House Urges Congress To Delay November Hemp Recriminalization
Biden administration calls for legislative fix to prevent broad hemp product ban set to take effect in five months.
More from the newsroom

Sacramento Approves Cannabis Lounges, But Licensing May Take Months
California's capital city clears the way for on-site consumption venues, though operators face a multi-stage permitting gauntlet.

California City Approves Cannabis Consumption Lounge Pilot Program
A California municipality has greenlit a pilot program for on-site cannabis consumption lounges, expanding retail options in the state.

Former Olympian Now Studies Cannabis After Career Under Ban
Joanna Zeiger, once forbidden to touch the plant, now leads research into its therapeutic potential for athletes.